NEWS

2024101

PR Notice Concerning Positive Recommendation from Safety Monitoring Committee for Continuing High-dose Arm in HS-001 Clinical Trial (LAPiS Study)

2024916

Seminar Heartseed CMO Takehiko Kaneko is Speaking at the "Global Innovations in Healthcare" Webinar

202493

Media An article by COO Kikuo Yasui on Japan's drug discovery ecosystem has been published in "BioSpectrum Asia".

202482

Media Heartseed was Featured on NHK World's "jib TV"

2024731

Congress Heartseed CMO Dr. Takehiko Kaneko to Speak at the 3rd Heart Failure Drug Discovery & Development Summit in Boston

2024730

PR Heartseed Announces Positive Recommendation from Safety Monitoring Committee for Dose Escalation in Phase 1/2 Clinical Trial Dosed With HS-001

2024730

PR Notice of Listing on the Growth Market of the Tokyo Stock Exchange

2024626

PR Notice of Approval for Listing on the Growth Market of the Tokyo Stock Exchange

202458

Congress Initial Results of the LAPiS Trial with HS-001 to Be Presented at the 2024 European Society of Cardiology - Heart Failure Congress

202452

PR Heartseed.'s CFO, Mutsuki Takano, Named "Most Innovative CFO from Asia to Watch in 2024" by CXO Magazine

1 2 3 4 5 6 7 8